Literature DB >> 21833026

Dysregulated pH: a perfect storm for cancer progression.

Bradley A Webb1, Michael Chimenti, Matthew P Jacobson, Diane L Barber.   

Abstract

Although cancer is a diverse set of diseases, cancer cells share a number of adaptive hallmarks. Dysregulated pH is emerging as a hallmark of cancer because cancers show a 'reversed' pH gradient with a constitutively increased intracellular pH that is higher than the extracellular pH. This gradient enables cancer progression by promoting proliferation, the evasion of apoptosis, metabolic adaptation, migration and invasion. Several new advances, including an increased understanding of pH sensors, have provided insight into the molecular basis for pH-dependent cell behaviours that are relevant to cancer cell biology. We highlight the central role of pH sensors in cancer cell adaptations and suggest how dysregulated pH could be exploited to develop cancer-specific therapeutics.

Entities:  

Mesh:

Year:  2011        PMID: 21833026     DOI: 10.1038/nrc3110

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  116 in total

1.  A rationalization of the acidic pH dependence for stromelysin-1 (Matrix metalloproteinase-3) catalysis and inhibition.

Authors:  L L Johnson; A G Pavlovsky; A R Johnson; J A Janowicz; C F Man; D F Ortwine; C F Purchase; A D White; D J Hupe
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

2.  Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis.

Authors:  S Matsuyama; J Llopis; Q L Deveraux; R Y Tsien; J C Reed
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

3.  Na-H exchange-dependent increase in intracellular pH times G2/M entry and transition.

Authors:  Luanna K Putney; Diane L Barber
Journal:  J Biol Chem       Date:  2003-08-28       Impact factor: 5.157

4.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

Authors:  C C Wykoff; N J Beasley; P H Watson; K J Turner; J Pastorek; A Sibtain; G D Wilson; H Turley; K L Talks; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

5.  Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin.

Authors:  Erica Miraglia; Daniele Viarisio; Chiara Riganti; Costanzo Costamagna; Dario Ghigo; Amalia Bosia
Journal:  Int J Cancer       Date:  2005-07-20       Impact factor: 7.396

Review 6.  The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis.

Authors:  Rosa A Cardone; Valeria Casavola; Stephan J Reshkin
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

7.  Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange.

Authors:  Christian Stock; Birgit Gassner; Christof R Hauck; Hannelore Arnold; Sabine Mally; Johannes A Eble; Peter Dieterich; Albrecht Schwab
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182

8.  Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.

Authors:  Alan Prem Kumar; Ai Li Quake; Michelle Ker Xing Chang; Ting Zhou; Kelly Swee Ying Lim; Rajeev Singh; Robert Edwin Hewitt; Manuel Salto-Tellez; Shazib Pervaiz; Marie-Véronique Clément
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

9.  Solution structure of human cofilin: actin binding, pH sensitivity, and relationship to actin-depolymerizing factor.

Authors:  Brian J Pope; Karen M Zierler-Gould; Ronald Kühne; Alan G Weeds; Linda J Ball
Journal:  J Biol Chem       Date:  2003-11-18       Impact factor: 5.157

10.  Positive feedback between Cdc42 activity and H+ efflux by the Na-H exchanger NHE1 for polarity of migrating cells.

Authors:  Christian Frantz; Anastasios Karydis; Perihan Nalbant; Klaus M Hahn; Diane L Barber
Journal:  J Cell Biol       Date:  2007-11-05       Impact factor: 10.539

View more
  514 in total

Review 1.  Store-Operated Calcium Channels.

Authors:  Murali Prakriya; Richard S Lewis
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

2.  Protonation and Trapping of a Small pH-Sensitive Near-Infrared Fluorescent Molecule in the Acidic Tumor Environment Delineate Diverse Tumors in Vivo.

Authors:  Rebecca C Gilson; Rui Tang; Avik Som; Chloe Klajer; Pinaki Sarder; Gail P Sudlow; Walter J Akers; Samuel Achilefu
Journal:  Mol Pharm       Date:  2015-11-04       Impact factor: 4.939

Review 3.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

4.  Separation of extra- and intracellular metabolites using hyperpolarized (13)C diffusion weighted MR.

Authors:  Bertram L Koelsch; Renuka Sriram; Kayvan R Keshari; Christine Leon Swisher; Mark Van Criekinge; Subramaniam Sukumar; Daniel B Vigneron; Zhen J Wang; Peder E Z Larson; John Kurhanewicz
Journal:  J Magn Reson       Date:  2016-07-09       Impact factor: 2.229

5.  Hybrid anisotropic nanostructures for dual-modal cancer imaging and image-guided chemo-thermo therapies.

Authors:  Ruiping Zhang; Kai Cheng; Alexander L Antaris; Xiaowei Ma; Min Yang; Sindhuja Ramakrishnan; Guifeng Liu; Alex Lu; Hongjie Dai; Mei Tian; Zhen Cheng
Journal:  Biomaterials       Date:  2016-07-02       Impact factor: 12.479

6.  pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs.

Authors:  Philip G Penketh; Richard A Finch; Rachel Sauro; Raymond P Baumann; Elena S Ratner; Krishnamurthy Shyam
Journal:  Chem Biol Drug Des       Date:  2017-07-17       Impact factor: 2.817

7.  6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors.

Authors:  Lei Wang; Adrianne Wallace; Sudhir Raghavan; Siobhan M Deis; Mike R Wilson; Si Yang; Lisa Polin; Kathryn White; Juiwanna Kushner; Steven Orr; Christina George; Carrie O'Connor; Zhanjun Hou; Shermaine Mitchell-Ryan; Charles E Dann; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2015-08-28       Impact factor: 7.446

8.  Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches.

Authors:  Hwai Wen Chang; Gerhard Frey; Haizhen Liu; Charles Xing; Lawrence Steinman; William J Boyle; Jay M Short
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

9.  Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy.

Authors:  A Sofia Silva; Kevin E Shopsowitz; Santiago Correa; Stephen W Morton; Erik C Dreaden; Teresa Casimiro; Ana Aguiar-Ricardo; Paula T Hammond
Journal:  Int J Pharm       Date:  2020-10-26       Impact factor: 5.875

10.  Propeptides of eukaryotic proteases encode histidines to exploit organelle pH for regulation.

Authors:  Johannes Elferich; Danielle M Williamson; Bala Krishnamoorthy; Ujwal Shinde
Journal:  FASEB J       Date:  2013-04-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.